Search Results - "Lozano, M.L"

Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia by Bastida, J. M., Benito, R., Janusz, K., Díez‐Campelo, M., Hernández‐Sánchez, J. M., Marcellini, S., Girós, M., Rivera, J., Lozano, M. L., Hortal, A., Hernández‐Rivas, J. M., González‐Porras, J. R.

“…Essentials Diagnosis of sitosterolemia, a rare recessive or syndromic disorder, is usually delayed. Peripheral blood smear is extremely useful for establishing…”
Get full text

Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor by GUERRERO, J. A., LOZANO, M. L., CASTILLO, J., BENAVENTE‐GARCÍA, O., VICENTE, V., RIVERA, J.

“…Background: Dietary flavonoids are known for their antiplatelet activity resulting in cardiovascular protection, although the specific mechanisms by which this…”
Get full text

Proteomic analysis of platelet N -glycoproteins in PMM2-CDG patients by de la Morena-Barrio, M.E, Di Michele, M, Lozano, M.L, Rivera, J, Pérez-Dueñas, B, Altisent, C, Sevivas, T, Vicente, V, Jaeken, J, Freson, K, Corral, J

“…Abstract PMM2-CDG, the most frequent congenital disorder of N- glycosylation, is an autosomal recessive disease with a multisystem presentation. PMM2-CDG…”
Get full text

PO-1517 Modelling the MLC Agility transmission radiation through the closed leaf gap in the Monaco TPS by Vicedo González, M.A., García Hernández, M.T., Planes Meseguer, D., García Molla, R., Bordería Navarro, B., Calatayud Cuesta, P., Alcaraz Lozano, M.L.

Get full text

PO-1547 End to end tests for Volumetric Modulated Arc Therapy using a new modular phantom by García Hernández, M.T., Vicedo González, A., García Mollá, R., Planes Meseger, D., Bordería Navarro, B., Calatayud Cuesta, P., Alcaraz Lozano, M.L.

Get full text

Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells by Aguilera, A, Aroeira, L S, Ramirez-Huesca, M, Perez-Lozano, M L, Cirugeda, A, Bajo, M A, Del Peso, G, Valenzuela-Fernandez, A, Sanchez-Tomero, J A, Lopez-Cabrera, M, Selgas, R

“…The preservation of the peritoneal membrane is crucial for long-term survival in peritoneal dialysis. Epithelial-to-mesenchymal transition (EMT) is a process…”
Get full text

Apigenin Inhibits Platelet Adhesion and Thrombus Formation and Synergizes with Aspirin in the Suppression of the Arachidonic Acid Pathway by Navarro-Núñez, L, Lozano, M. L, Palomo, M, Martínez, C, Vicente, V, Castillo, J, Benavente-García, O, Diaz-Ricart, M, Escolar, G, Rivera, J

“…Previous studies using washed platelets demonstrated that certain flavonoids inhibit platelet function through several mechanisms including blockade of TxA2…”
Get full text

PS1482 EFFECT OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO‐RAS) ON ENDOTHELIAL CELLS AND NEUTROPHIL EXTRACELLULAR TRAP (NET) FORMATION IN IMMUNE THROMBOCYTOPENIA (ITP) by Garabet, L., Henriksson, C.E., Ghanima, W., Bussel, J., Mowinckel, M.‐C., Brodin, E., Fernández‐Pérez, M.P., Martínez, C., González‐Conejero, R., Lozano, M.L., Sandset, P.M.

“…Background: ITP patients have an increased risk of thrombosis, and TPO‐RA‐treatment may further increase this risk. Studies have shown that procoagulant…”
Get full text

PS1497 NEUTROPHIL EXTRACELLULAR TRAPS (NETS), BLOOD CELL COUNTS AND THROMBOTIC RISK IN ITP PATIENTS by Lozano, M.L., Fernandez‐Perez, M.P., De Los Reyes‐Garcia, A.M., Diaz‐Lozano, P., Garcia‐Barbera, N., Garabet, L., Ghanima, W., Martinez, C., Gonzalez‐Conejero, R.

“…Background: Patients with immune thrombocytopenia (ITP) are at increased risk of vascular events (VE), but the precise mechanisms of this prothrombotic state…”
Get full text

261 - What is the Outcome of Patients in the Intermediate IPSS-R Score Group? Spanish Approach for Better Stratification with Classical Tools by Guijo, A.M. Redondo, Sánchez-Barba, M., Santillana, G. Sanz, Bernal, T., Sangerman, M. Arnan, Ortega, F. Ramos, Olivé, C. Pedro, Lozano, M.L. Amigo, Betes, V. Marco, Valcárcel, D., Ardanaz, M., Brunet, S., Lleonart, J. Bargay, Tormo, M., Xicoy, B., Nomdedeu, M., Cadenas, F. López, Berrocal, J.C. Caballero, Cañizo, M.C.D., Díez-Campelo, M.

Get full text

Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic Cells: Implications in Cell Reprogramming and Stem Cell Therapy by Navarro, S., Moleiro, V., Molina‐Estevez, F.J., Lozano, M.L., Chinchon, R., Almarza, E., Quintana‐Bustamante, O., Mostoslavsky, G., Maetzig, T., Galla, M., Heinz, N., Schiedlmeier, B., Torres, Y., Modlich, U., Samper, E., Río, P., Segovia, J.C., Raya, A., Güenechea, G., Izpisua‐Belmonte, J.C., Bueren, J.A.

“…Fanconi anemia (FA) is a complex genetic disease associated with a defective DNA repair pathway known as the FA pathway. In contrast to many other FA proteins,…”
Get full text

What is the Outcome of Patients in the Intermediate IPSS-R Score Group? Spanish Approach for Better Stratification with Classical Tools by Guijo, A.M. Redondo, Sánchez-Barba, M, Santillana, G. Sanz, Bernal, T, Sangerman, M. Arnan, Ortega, F. Ramos, Olivé, C. Pedro, Lozano, M.L. Amigo, Betes, V. Marco, Valcárcel, D, Ardanaz, M, Brunet, S, Lleonart, J. Bargay, Tormo, M, Xicoy, B, Nomdedeu, M, Cadenas, F. López, Berrocal, J.C. Caballero, Cañizo, M.C.D, Díez-Campelo, M

Get full text

PF690 PREDICTORS OF THERAPY FREE RESPONSES IN ITP PATIENTS RECEIVING TPO‐RA. RESULTS FROM A SPANISH MULTICENTER STUDY by Lozano, M.L., Mingot, M.E., Perera, M., Jarque, I., Campos, R., González, T.J., Carreño, G., Bermejo, N., López, M.F., Andrés, A., Valcárcel, D., Casado, F., Álvarez, M.T., Orts, M.I., Novelli, S., Revilla, N., González, J.R., Bolaños, E., Ansoar, E. López, Orna, E., Vicente, V.

“…Background: Thrombopoietin receptor agonists (TPO‐RA) are a well‐established treatment in patients with primary immune thrombocytopenia (ITP). Sustained…”
Get full text

PS1580 PREVALENCE AND RISK FACTORS FOR THROMBOSIS IN ADULT ITP PATIENTS TREATED WITH TPO‐RA by Lozano, M.L., Mingot, M.E., Perera, M., Jarque, I., Campos, R., González, T.J., Carreño, G., Bermejo, N., López, M.F., Andrés, A., Valcárcel, D., Casado, F., Álvarez, M.T., Orts, M.I., Novelli, S., González, J.R., Bolaños, E., Ansoar, E. López, Orna, E., Vicente, V.

“…Background: Thrombopoietin‐receptor‐agonists (TPO‐RA) are effective treatments of immune thrombocytopenia (ITP). Previous long‐term TPO‐RA clinical trials have…”
Get full text

PF339 BIOLOGICAL AND CLINICAL FACTORS THAT FAVOR THE USE OF A SPECIFIC TPO‐RA IN ITP PATIENTS. RESULTS FROM A SPANISH MULTICENTER STUDY by Lozano, M.L., Mingot, M.E., Perera, M., Jarque, I., Campos, R., González, T.J., Carreño, G., Bermejo, N., López, M.F., Andrés, A., Valcárcel, D., Casado, F., Álvarez, M.T., Orts, M.I., Novelli, S., Revilla, N., González, J.R., Bolaños, E., López Ansoar, E., Orna, E., Vicente, V.

“…Background: To date there are no head‐to‐head randomized controlled trials comparing romiplostim (ROM) with eltrombopag (ELT) for the management of patients…”
Get full text

First European haematopoietic progenitor cell transplant unit obtaining re-accreditation of a JACIE quality system: experience and difficulties for implantation by Nieto, J, Castilla, C, Marquez, J, Heras, I, Vicente, V, de Arriba, F, Rivera, J, Martinez, J. Tomas, Lozano, M.L

“…Directive 2004/23/EC of the European Parliament and of the Council sets rules and standards of quality and safety for the donation, procurement, testing,…”
Get full text

PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION by Moreno, M.J., Martínez, C., Navarro-Núñez, L., Ferrer, F., Vicente, V., Lozano, M.L., González, M.H., Rivera, J.

Get full text

Prospective multi-center national study to standardize the follow-up of type 1 Gaucher disease patients treated with eliglustat under standard of care practice: TRAZELGA project by Andrade-Campos, Marcio M., Cebolla, Jorge J., de Frutos, Laura Lopez, Irun, Pilar, Noya, Maria Soledad, Nieto, S., Villalon, Lucia, Arribas, A.I., Barez, Abelardo, Garcia-Frade, Javier, Hermosin, N., Rivas, Jose Maria Hernandez, Ibarretxe, Daiana, Lozano Almela, M.L., Molero, Maria T., Morado, M., Perez Saenz, M.A., Villarrubia, Jesus, Giraldo, Pilar

Get full text

“Olvidar” una patología en la anamnesis ¿puede acortar la vida del paciente? by Lozano-Sánchez, M.L, Leal-Hernández, M, Pascual-Aguirre, N, Berrospi-Melgarejo, J.M

“…La realización adecuada y exhaustiva de la anamnesis es de suma importancia para el médico de Atención Primaria. Presentamos un varón de 61 años que consulta…”
Get full text

Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: impact of filtration timing by Ferrer, F., Rivera, J., Corral, J., Gonzalez-Conejero, R., Lozano, M.L., Vicente, V.

“…BACKGROUND: Concern for the undesirable consequences of transfusing passenger WBCs is leading to the general use of WBC‐reduced platelet concentrates (PCs)…”
Get full text